Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 6

Erratum

Authors Rapidis A, Sarlis N, Lefebvre J, Kies M

Published 5 December 2008 Volume 2008:4(6) Pages 1381—1381

DOI https://doi.org/10.2147/TCRM.S5436

Rapidis A, Sarlis N, Lefebvre J-L, et al. 2008. Docetaxel in the treatment of squamous cell carcinoma of the head and neck. Ther Clin Risk Manag, 4:865–886

Page 870, right column of text: TPF and PF were given for 3 cycles not 4 cycles.

Page 871, Table 2 caption should read: TAX 323: select efficacy and safety results.

Page 872, Table 3 caption should read: TAX 324: select efficacy and safety results.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other article by this author:

Docetaxel in the treatment of squamous cell carcinoma of the head and neck

Alexander Rapidis, Nicholas Sarlis, Jean-Louis Lefebvre, Merrill Kies

Therapeutics and Clinical Risk Management 2008, 4:865-886

Published Date: 10 October 2008

Readers of this article also read:

Preparation and characterization of gadolinium-loaded PLGA particles surface modified with RGDS for the detection of thrombus

Zhang Y, Zhou J, Guo D, Ao M, Zheng Y, Wang Z

International Journal of Nanomedicine 2013, 8:3745-3756

Published Date: 1 October 2013

An observational study of bimatoprost 0.01% in treatment-naïve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial

Nixon DR, Simonyi S, Bhogal M, Sigouin CS, Crichton AC, Discepola M, Hutnik CML, Yan DB

Clinical Ophthalmology 2012, 6:2097-2103

Published Date: 18 December 2012

Solid lipid nanoparticle suspension enhanced the therapeutic efficacy of praziquantel against tapeworm

Xie S, Pan B, Shi B, Zhang Z, Zhang X, Wang M, Zhou W

International Journal of Nanomedicine 2011, 6:2367-2374

Published Date: 18 October 2011

Corrigendum

Schneider EW, Johnson MW

Clinical Ophthalmology 2011, 5:1315-1316

Published Date: 16 September 2011

Tetracaine 0.5% eyedrops with or without lidocaine 2% gel in topical anesthesia for cataract surgery

Anthoula T Tsoumani, Ioannis C Asproudis, Dimitrios Damigos

Clinical Ophthalmology 2010, 4:967-970

Published Date: 24 August 2010

Interferons and their potential in the treatment of ocular inflammation

Friederike Mackensen, Regina Max, Matthias D Becker

Clinical Ophthalmology 2009, 3:559-566

Published Date: 16 October 2009